BREAST CANCER, METASTATIC
Clinical trials for BREAST CANCER, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER, METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune therapy trial offers hope for Tough-to-Treat breast cancer
Disease control CompletedThis study tested a two-part immunotherapy for people with advanced breast cancer that had spread or returned after standard treatments failed. The treatment combined a personalized cell-based vaccine (SV-BR-1-GM) with an immune-boosting drug (retifanlimab). The main goals were t…
Matched conditions: BREAST CANCER, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Targeted pill challenges chemo for inherited breast cancer
Disease control CompletedThis completed Phase 3 trial compared a daily oral medication called olaparib against standard chemotherapy chosen by doctors. It involved 302 patients with metastatic breast cancer who have specific inherited BRCA gene mutations. The study aimed to see if the targeted pill could…
Matched conditions: BREAST CANCER, METASTATIC
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for aggressive breast cancer: drug combo trial shows promise
Disease control CompletedThis study compared two treatment approaches for people with advanced, aggressive breast cancer that has spread and cannot be removed by surgery. One group received a newer targeted pill (abemaciclib) plus standard hormone therapy. The other group started with a short course of c…
Matched conditions: BREAST CANCER, METASTATIC
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC